|
Date: |
Saturday, September 29, 2007 |
|
Course #: |
2714126 |
|
Who should Attend? |
Physicians, Nurses, Physician Assistants, Pharmacists, Hospitalists, and Hospital Administrators interested in thrombosis prevention and treatment. |
| Tuition: |
There is no cost to attend this program. Pre-registration is required. |
| Location: |
The Fairmont Copley Plaza Hotel, 138 St. James Avenue, Boston, MA 02116 |
| Directors: |
Samuel Z. Goldhaber, MD, Jawed Fareed, PhD, and Arthur A. Sasahara, MD |
| Offered by: |
North American Thrombosis Forum (NATF), Brigham and Women's Hospital, Department of Medicine, and Harvard Medical School, Department of Continuing Education |
| Objectives: |
This 1-day symposium emphasizing Clinical Science and professional education is intended to provide a concise, state-of-the-art overview of prophylaxis measures and critical developments in the diagnosis, treatment, and prevention of thrombotic disorders. Focused sessions in 5 key areas include 1) translational research, 2) clinical research, 3) prevention and education, 4) public policy, and 5) advocacy (featuring special guest lecturers Melanie Bloom, Ajay Kakkar, MD, Sanjay Kaul, MD, MPH, and Susan B. Shurin, MD).*
The course will be presented in multiple formats: 1) lectures, 2) discussion with questions and answers following each lecture, and 3) summary of the 5 Thrombosis Summit Working Groups, presented by the Directors of the North American Thrombosis Forum (NATF).
Course Participants will receive a comprehensive syllabus and CD ROM, which includes lecture outlines with slide panels and extensive up-to-date bibliographies.
*Due to circumstances beyond our control, Rear Admiral Kenneth Moritsugu will not be attending the Thrombosis Summit. |
| NATF: |
Board of Directors and Officers
Samuel Z. Goldhaber, MD – President
Jawed Fareed, PhD – Director
Arthur A. Sasahara, MD – Director
John Fanikos, RPh, MBA – Director, Treasurer
Administrator
Kim D. Mahoney – Executive Director, Secretary |
Scientific Advisory Committee:
Geno Merli, MD – Chair
Jeanine M. Walenga, PhD – Vice Chair
Stephen Fredd, MD
Carlos Jerjes-Sanchez Diaz, MD
Kenneth V. Leeper, Jr, MD
Gundu Rao, PhD
Jeffrey I. Weitz, MD
Ann K. Wittkowsky, PharmD |
| Faculty: |
Deepak L. Bhatt, MD
Melanie Bloom
Gideon Bosker, MD
Julie E. Buring, ScD
Gregory J. Del Zoppo, MD
C. Gregory Elliott, MD
Jawed Fareed, PhD
Samuel Z. Goldhaber, MD
Ajay K. Kakkar, MD, PhD
Sanjay Kaul, MD, MPH
|
Craig M. Kessler, MD
Geno Merli, MD
Ruth B. Morrison, RN, BSN, CVN
Thomas Ortel, MD, PhD
Paul M. Ridker, MD, MPH
Arthur A. Sasahara, MD
Susan B. Shurin, MD
Jeanine M. Walenga, PhD
Jeffrey I. Weitz, MD
|
| Honored Guests: |
Melanie Bloom, Coalition to Prevent DVT. Widow of former NBC war correspondent David Bloom, who succumbed to massive pulmonary embolism on the outskirts of Baghdad.
Ajay K. Kakkar, MD, PhD. Barts and the London, Queen Mary School of Medicine and Dentistry; Consultant Surgeon, St. Bartholomews Hospital, London; Director, Designate, Thrombosis Research Institute; Professor of Surgical Sciences; Department of Surgical Oncology and Technology; Imperial College, Hammersmith Campus, London, UK.
Sanjay Kaul, MD, MPH. Director of the Vascular Physiology and Thrombosis Research Laboratory at the Burns and Allen Research Institute at Cedars-Sinai Medical Center in Los Angeles, California.
Susan B. Shurin, MD, Deputy Directory of the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH). Dr. Shurin was Professor of Pediatrics and Oncology at Case Western Reserve University and Chief of Pediatric Hematology/Oncology at Rainbow Babies and Children’s Hospital in Cleveland. Dr. Shurin is currently leading NHLBI efforts to enhance the clinical research program. |
SCHEDULE – THROMBOSIS SUMMIT 2007
Saturday, September 29, 2007
The Fairmont Copley Plaza Hotel |
6:45 – 7:30 a.m.
7:30 – 7:45 a.m.
7:45 – 8:00 a.m.
|
Registration and Seating - Continental Breakfast
Seating
Welcome and Introductions - Samuel Z. Goldhaber, MD, Jawed Fareed, PhD, and Arthur A. Sasahara, MD |
TRANSLATIONAL RESEARCH: |
8:00 – 8:25 a.m.
8:25
– 8:50 a.m.
8:50
– 9:15 a.m. |
Genetics and Cardiovascular Thrombosis
Heparin Induced Thrombocytopenia
Thrombophilia |
Paul M Ridker, MD, MPH
Jeanine M. Walenga, PhD
Thomas J. Ortel, MD, PhD |
CLINICAL RESEARCH: |
9:15 – 9:40 a.m.
9:40 – 10:05 a.m.
10:05
– 10:30 a.m.
10:30
– 10:55 a.m.
|
Stroke
New Antithrombotic Agents
Reversal of Hemorrhage
Prevention of Venous Thromboembolism |
Gregory J. del Zoppo, MD
Jeffrey I. Weitz, MD
Craig M. Kessler, MD
C. Gregory Elliott, MD |
PREVENTION AND EDUCATION: |
10:55 – 11:20 a.m.
11:00 – 12:00 p.m.
12:00
– 12:10 p.m.
12:10 – 12:35 p.m. |
Prevention of Stroke and Heart Attack
Lunch Break
Seating
Education of Health Care Professionals |
Julie E. Buring, ScD
Gideon Bosker, MD |
| PUBLIC POLICY: |
12:35 – 1:00 p.m.
1:00 – 1:25 p.m.
1:25 – 1:50 p.m.
1:50 – 2:15 p.m.
2:15 – 2:40 p.m.
2:40 – 3:00 p.m.
|
The British Parliament
The United States Congress
Antithrombotic Therapy for Acute Coronary Syndromes
Coronary Artery Disease and Health Policy
Surgeon General’s Workshop: "Call To Action: DVT"
Afternoon Break |
Ajay K. Kakkar, MD
Geno Merli, MD
Sanjay Kaul, MD, MPH
Deepak L. Bhatt, MD
Samuel Z. Goldhaber, MD
Afternoon Break |
| ADVOCACY: |
3:00 – 3:25 p.m.
3:25
– 3:50 p.m.
3:50
– 4:15 p.m.
4:15 – 4:45 p.m.
4:45 – 5:00 p.m.
5:00 p.m. |
The National Heart, Lung and Blood Institute (NIH)
The Pulmonary Embolism Support Group
Patient and Family Advocacy
Summaries from the 5 Thrombosis Summit Working Groups
Concluding Comments, Future Plans, and Wrap-up
Adjourn |
Susan Shurin, MD
Ruth B. Morrison, RN, BSN, CVN
Melanie Bloom
NATF Advisory Committee
NATF Directors
Adjourn |
* Each lecture will close with a 5-10 minute discussion/question and answer period. |
|
|
|
|
